Operating Lease, Right-of-Use Asset in USD of Sigyn Therapeutics, Inc. from Q2 2021 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Sigyn Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q2 2021 to Q1 2025.
  • Sigyn Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2025 was $97.2K, a 37.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Sigyn Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2025 $97.2K -$57.2K -37.1% 31 Mar 2025 10-Q 20 May 2025
Q4 2024 $112K -$55.7K -33.2% 31 Dec 2024 10-Q 14 Nov 2025
Q3 2024 $127K -$54.2K -30% 30 Sep 2024 10-Q 19 Nov 2024
Q2 2024 $141K -$52.7K -27.3% 30 Jun 2024 10-Q 19 Aug 2024
Q1 2024 $154K -$51.3K -25% 31 Mar 2024 10-Q 14 May 2024
Q4 2023 $168K -$50K -23% 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 $181K -$48.7K -21.2% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $193K -$47.4K -19.7% 30 Jun 2023 10-Q 14 Aug 2023
Q1 2023 $206K -$46.2K -18.3% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $218K -$45.1K -17.1% 31 Dec 2022 10-K 20 Feb 2024
Q3 2022 $229K -$46.9K -17% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $241K -$46.4K -16.1% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $252K 31 Mar 2022 10-Q 13 May 2022
Q4 2021 $263K 31 Dec 2021 10-K 31 Mar 2023
Q3 2021 $276K 30 Sep 2021 10-Q 12 Nov 2021
Q2 2021 $287K 30 Jun 2021 10-Q 16 Aug 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.